UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BAR-Seq clonal tracking of gene-edited cells

Nature protocols, 2021-06, Vol.16 (6), p.2991-3025

2021

Volltextzugriff (PDF)

Diaphragm ultrasound evaluation during weaning from mechanical ventilation in COVID-19 patients: a pragmatic, cross-section, multicenter study

Respiratory research, 2022-08, Vol.23 (1), p.1-210, Article 210

2022

Volltextzugriff (PDF)

A step toward stem cell engineering in vivo

Science (American Association for the Advancement of Science), 2023-07, Vol.381 (6656), p.378-379

2023

Volltextzugriff (PDF)

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation

Frontiers in genome editing, 2021-03, Vol.3, p.618378-618378

2021

Volltextzugriff (PDF)

A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis

JHLT Open, 2024-08, Vol.5, p.100106, Article 100106

2024

Volltextzugriff (PDF)

Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo

Molecular therapy. Methods & clinical development, 2023-09, Vol.30, p.546-557

2023

Volltextzugriff (PDF)

P1405: IN‐DEPTH GENOME INTEGRITY EVALUATION AND GMP‐COMPLIANT MANUFACTURING OF HDR GENE EDITED CD4+ T CELLS FOR THE TREATMENT OF HYPER IGM 1

HemaSphere, 2023-08, Vol.7 (S3), p.e6715437-n/a

2023

Volltextzugriff (PDF)

S255: CELLULAR SENESCENCE AND INFLAMMATORY PROGRAMS ARE UNINTENDED CONSEQUENCES OF CRISPR‐CAS9 GENE EDITING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS

HemaSphere, 2023-08, Vol.7 (S3), p.e7928137-n/a

2023

Volltextzugriff (PDF)

P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS

HemaSphere, 2023-08, Vol.7 (S3), p.e6237653-n/a

2023

Volltextzugriff (PDF)

Correcting inborn errors of immunity: From viral mediated gene addition to gene editing

Seminars in immunology, 2023-03, Vol.66, p.101731-101731, Article 101731

2023

Volltextzugriff (PDF)

Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy

Cell stem cell, 2023-05, Vol.30 (5), p.549-570

2023

Volltextzugriff (PDF)

Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation

British medical bulletin, 2023-09, Vol.147 (1), p.108-120

2023

Volltextzugriff (PDF)

Genotoxic effects of base and prime editing in human hematopoietic stem cells

Nature biotechnology, 2023-09

2023

Volltextzugriff (PDF)

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

Cell, 2022-06, Vol.185 (13), p.2248-2264.e21

2022

Volltextzugriff (PDF)

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells

Blood, 2023-08, Vol.142 (9), p.812-826

2023

Volltextzugriff (PDF)

Assessing Stealth and Sensed Base Editing in Human Hematopoietic Stem/Progenitor Cells

Blood, 2021-11, Vol.138 (Supplement 1), p.3976-3976

2021

Volltextzugriff (PDF)

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells

Cell stem cell, 2022-10, Vol.29 (10), p.1428-1444.e9

2022

Volltextzugriff (PDF)

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential

Biochimica et biophysica acta. Molecular cell research, 2024-12, Vol.1871 (8), p.119818, Article 119818

2024

Volltextzugriff (PDF)

Author Correction: Genotoxic effects of base and prime editing in human hematopoietic stem cells

Nature biotechnology, 2024-06

2024

Volltextzugriff (PDF)

1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS

Experimental hematology, 2022, Vol.111, p.S22-S22

2022

Volltextzugriff (PDF)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs

Molecular therapy, 2023-01, Vol.31 (1), p.230-248

2023

Volltextzugriff (PDF)

Ultrasound localization of central vein catheter tip by contrast-enhanced transthoracic ultrasonography: a comparison study with trans-esophageal echocardiography

Critical care (London, England), 2022-04, Vol.26 (1), p.113-113, Article 113

2022

Volltextzugriff (PDF)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs

Molecular therapy, 2022-10, Vol.30 (10), p.3333-3333

2022

Volltextzugriff (PDF)

Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T‐cells for the treatment of Hyper IgM1

The EMBO journal, 2023-12, Vol.42 (23), p.e114188-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Englisch
(78)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

BAR-Seq clonal tracking of gene-edited cells

Diaphragm ultrasound evaluation during weaning from mechanical ventilation in COVID-19 patients: a pragmatic, cross-section, multicenter study

A step toward stem cell engineering in vivo

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation

A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis

Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo

P1405: IN‐DEPTH GENOME INTEGRITY EVALUATION AND GMP‐COMPLIANT MANUFACTURING OF HDR GENE EDITED CD4+ T CELLS FOR THE TREATMENT OF HYPER IGM 1

S255: CELLULAR SENESCENCE AND INFLAMMATORY PROGRAMS ARE UNINTENDED CONSEQUENCES OF CRISPR‐CAS9 GENE EDITING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS

P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS

Correcting inborn errors of immunity: From viral mediated gene addition to gene editing

Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy

Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation

Genotoxic effects of base and prime editing in human hematopoietic stem cells

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells

Assessing Stealth and Sensed Base Editing in Human Hematopoietic Stem/Progenitor Cells

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells

Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potential

Author Correction: Genotoxic effects of base and prime editing in human hematopoietic stem cells

1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs

Ultrasound localization of central vein catheter tip by contrast-enhanced transthoracic ultrasonography: a comparison study with trans-esophageal echocardiography

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs

Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T‐cells for the treatment of Hyper IgM1

Unraveling Pathophysiology and Hematopoiesis of Vexas Syndrome By Multi-Omics Analyses and Targeted Gene Editing

Suchergebnisse filtern